Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glucocorticoids and sepsis.

J Allary1, D Annane

  • 1Department of Anesthesiology and Critical Care, Raymond Poincaré Hospital, University of Medicine, Paris Ile de France Ouest, Garches, France.

Minerva Anestesiologica
|November 17, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Homozygous DNAJB4 deletion revealing myopathy with acute respiratory failure.

Revue neurologique·2025
Same author

Nusinersen treatment in adults with severe spinal muscular atrophy: A real-life retrospective observational cohort study.

Revue neurologique·2022
Same author

Perioperative fluid management for major elective surgery.

The British journal of surgery·2020
Same author

Mismatch negativity to predict subsequent awakening in deeply sedated critically ill patients.

British journal of anaesthesia·2018
Same author

Outcome of bloodstream infections among spinal cord injury patients and impact of multidrug-resistant organisms.

Spinal cord·2016
Same author

Blood stream infections due to multidrug-resistant organisms among spinal cord-injured patients, epidemiology over 16 years and associated risks: a comparative study.

Spinal cord·2016
Same journal

Rectus sheath block for analgesia in open abdominal surgery: a systematic review, meta-analysis and trial sequential analysis.

Minerva anestesiologica·2026
Same journal

Highlights from the June 2026 issue.

Minerva anestesiologica·2026
Same journal

Validation of the Gendolcat model for chronic postsurgical pain after cesarean section: a multicenter study.

Minerva anestesiologica·2026
Same journal

Dual block strategy for complex incision in pediatric kidney transplantation: M-TAPA and quadroiliac plane block combination.

Minerva anestesiologica·2026
Same journal

Technical note: a novel fully visualized, glottic-sparing strategy for infant one-lung ventilation.

Minerva anestesiologica·2026
Same journal

Ultrasound-guided recto-intercostal fascial plane block facilitating early extubation following pediatric subxiphoid pericardial window surgery.

Minerva anestesiologica·2026
See all related articles

Low-dose corticosteroid therapy for septic shock significantly reduces mortality by improving shock duration and organ dysfunction. This treatment addresses glucocorticoid insufficiency common in sepsis management.

Area of Science:

  • Critical Care Medicine
  • Endocrinology
  • Pharmacology

Background:

  • Systemic inflammation defines sepsis, yet glucocorticoid use has been debated.
  • Glucocorticoids influence metabolism, immunity, and cardiovascular function during sepsis.
  • Glucocorticoid insufficiency, due to inadequate cortisol production or resistance, is prevalent in sepsis.

Purpose of the Study:

  • To summarize the rationale, timing, and methodology for using glucocorticoids in septic shock management.
  • To highlight the benefits of glucocorticoid replacement therapy in sepsis.

Main Methods:

  • Review of recent randomized trials on corticosteroid replacement therapy in septic shock.
  • Analysis of glucocorticoid interactions with metabolic, immune, and cardiovascular systems in sepsis.

Related Experiment Videos

Main Results:

  • Long-term, low-dose corticosteroid therapy demonstrated reduced mortality in septic shock.
  • Improvements observed include decreased shock duration, attenuated inflammatory response, and lessened organ dysfunction.

Conclusions:

  • Glucocorticoid replacement therapy is beneficial for managing septic shock.
  • Effective use involves understanding the 'why, when, and how' of administration in septic shock patients.